WCN26-4847 Multi-Dimensional Research On IgAN Prevention, Diagnosis And Treatment

Read full text Summarise with VIRAT
Authors: Wanting Ren, Jia Lv, Hongzhu Liu, Xuehong Lu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Immunoglobulin A nephropathy (IgAN) is currently the most prevalent primary glomerular disease worldwide, with a particularly high incidence in the Asian population. Clinical studies have demonstrated that approximately 20%–40% of IgAN patients may progress to end-stage renal disease (ESRD). Therefore, in-depth investigations into the risk assessment of IgAN, its early diagnosis and prognostic prediction, the elucidation of its pathogenesis, and the optimization of therapeutic strategies—all aimed at improving patients' long-term prognosis—hold significant clinical value and scientific significance.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104342–104342
Publication date
25 March 2026
Language
EN